ResMed : to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
January 12, 2023 at 04:40 pm IST
Share
SAN DIEGO, January 12, 2023 - ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2023 on Thursday, January 26, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
Location: http://investor.resmed.com
Date: Thursday, January 26, 2023
Time: 1:30 p.m. PDT / 4:30 p.m. EDT
International:
London, Thursday, January 26, 2023, 9:30 p.m. GMT
Sydney, Friday, January 27, 2023, 8:30 a.m. AEDT
Please note: ResMed does not use outside phone lines to access the earnings call; the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed's website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from January 26, 2023, until February 9, 2023, at:
U.S.: +1 877.660.6853
International: +1 201.612.7415
Conference ID: 13735371
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
ResMed Inc. published this content on 12 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 January 2023 11:09:06 UTC.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.